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Abstract
Background: Mouse embryonic stem (ES) cells remain pluripotent in vitro when grown in the
presence of the cytokine Leukaemia Inhibitory Factor (LIF). Identification of LIF targets and of genes
regulating the transition between pluripotent and early differentiated cells is a critical step for
understanding the control of ES cell pluripotency.
Results: By gene profiling studies carried out with mRNAs from ES cells and their early derivatives
treated or not with LIF, we have identified i) LIF-dependent genes, highly expressed in pluripotent
cells, whose expression level decreases sharply upon LIF withdrawal [Pluri genes], ii) LIF induced
genes [Lifind genes] whose expression is differentially regulated depending upon cell context and
iii) genes specific to the reversible or irreversible committed states. In addition, by hierarchical gene
clustering, we have identified, among eight independent gene clusters, two atypical groups of genes,
whose expression level was highly modulated in committed cells only. Computer based analyses
led to the characterization of different sub-types of Pluri and Lifind genes, and revealed their
differential modulation by Oct4 or Nanog master genes. Individual knock down of a selection of Pluri
and Lifind genes leads to weak changes in the expression of early differentiation markers, in cell
growth conditions in which these master genes are still expressed.
Conclusion: We have identified different sets of LIF-regulated genes depending upon the cell state
(reversible or irreversible commitment), which allowed us to present a novel global view of LIF
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responses. We are also reporting on the identification of genes whose expression is strictly
regulated during the commitment step. Furthermore, our studies identify sub-networks of genes
with a restricted expression in pluripotent ES cells, whose down regulation occurs while the master
knot (composed of OCT4, SOX2 and NANOG) is still expressed and which might be down-
regulated together for driving cells towards differentiation.
Background
Mouse embryonic stem cells (ES), which are derived from
the inner cell mass of blastocysts, are valuable for studying
pluripotency. Indeed, these cells recapitulate the complete
mouse developmental program when injected into ferti-
lized eggs and are widely used to introduce targeted muta-
tions in mice [1,2]. In addition, they can be induced to
differentiate in vitro to various cell types of the three germ
layers and are therefore of great interest for study signal-
ling pathways leading to specialized cell differentiation
[3-5]. Knowledge of molecular determinants that regulate
stem cell fate and understanding their functions are key
challenges for future therapy based on stem cells in which
their plasticity has to be properly controlled.
Two major pathways have been characterized so far, lead-
ing to the identification of "master genes" critical for the
maintenance of mouse ES cell pluripotency: the LIF/
STAT3 pathway, which synergizes with BMP2/4 and/or
Wnt family members (as Wnt3a, Wnt5a and Wnt6, [6-8]),
to maintain ES cell pluripotency alone [9-14], and the
OCT4/SOX2 and NANOG pathways, the last one identi-
fied in cells in which the LIF pathway has been knocked-
down [15-20]. The many known regulators of ES cell
pluripotency, like c-yes, [21], c-myc, [22], foxd3 [20] and
those characterized by gene profiling studies [23-26]
might be classified in one or the other pathway. However,
the exhaustive characterisation of transcriptional targets
of LIF in ES cells and in their early differentiated deriva-
tives has not been reported and the specificity of LIF tar-
gets versus those of OCT4 or NANOG has not yet been
investigated [27-29].
LIF is a member of the Interleukin-6 (IL-6) family of
cytokines, which displays pleiotropic functions, depend-
ing on both cell maturity and cell type [30-32]. Indeed,
while LIF maintains ES cell pluripotency and is a critical
cell survival factor in myocytes, embryonic germ cells, par-
ticular subtypes of neurons and osteoblasts, it induces dif-
ferentiation of the M1 leukemic myeloid cell line, can
switch the identity of neurons [33], induces cell cycle
arrest in cancer cells [34] and has a key pro-apoptotic role
during the post-gestation process of mammary gland
involution [35-37].
In mouse ES cells, LIF induces signalling pathways includ-
ing JAK1/STAT3/MYC/CD9/SOCS3/PI3K and ERK/RSK/
CREB leading to activation of both anti- and pro-differen-
tiative signals [23,38-44]. The transcriptional targets of
LIF are the outcomes of these signalling cascades and their
identification is a critical step for understanding the con-
trol of ES cell pluripotency. Also, LIF-dependent gene pro-
filing performed in various cell states (pluripotent,
reversible and irreversible commitment), should help to
define different groups of LIF responsive genes, leading to
a better understanding of pleiotropic effects of this
cytokine.
The aim of this study was to characterize the LIF transcrip-
tome of mouse ES cells as well as to identify novel regula-
tors of the transition from pluripotent to irreversibly
committed cells. By gene profiling studies, performed on
ES cells cultured under various conditions, we have iden-
tified eight independent gene clusters including a novel
gene category whose expression level varies transiently in
reversibly committed cells only. Moreover, our strategy
allowed us to identify different sets of LIF-regulated genes
and to define those ones also regulated by OCT4 or
NANOG. The effects of selected genes on ES cell differen-
tiation were also investigated.
Results
1) – LIF targets in mouse ES cells: experimental design
To identify LIF targets in pluripotent and committed-
derived ES cells as well as key genes regulated during the
transition from pluripotent to early differentiated cells, we
carried out an experimental strategy based on these three
facts i) A complete change of cell culture medium (includ-
ing serum and LIF) is required every 48 h to induce a
boost in STAT3 phosphorylation allowing cells to remain
pluripotent, ii) 24 h after LIF withdrawal, STAT3 is inacti-
vated by dephosphorylation and if incubated for longer in
the absence of LIF, ES cells will differentiate. However, if
LIF is added back 24 h after its withdrawal, differentiation
is prevented and cells maintain their pluripotent state.
Cells generated following 24 h of LIF starvation can there-
fore be categorised as in a state of reversible commitment,
iii) 48 h following LIF withdrawal, while remaining LIF-
sensitive, cells are irreversibly committed to differentiate.
Indeed, even if LIF is added back, cells differentiate and a
proportion of them die by apoptosis [24,38,45-47]. The
LIF-dependent kinetic experiments of STAT3 activation
showed a maximal stimulation at 30 min., which corre-
sponds to the maximal level of phospho-tyr705 and phos-BMC Genomics 2009, 10:73 http://www.biomedcentral.com/1471-2164/10/73
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The experimental strategy Figure 1
The experimental strategy. A1) Western blot analyses showing STAT3 and P-STAT3 and A2) band shift analyses of spe-
cific LIF-dependent complexes in ES cells depleted of LIF for 24 h and reinduced with LIF for 10 to 120 min. or in pluripotent 
cells (+ LIF) as indicated. LIF specific complexe containing STAT3 (arrow) and non specific complexe (asterisk) are indicated. 
B) Diagram summarising the cell growth conditions used for microarray experiments: Mouse ES cells, in the pluripotent state 
(grown with LIF for 48 h, Pluri.) or induced to differentiate by LIF withdrawal for 24 h [reversible commitment (Rev.)] or 48 h 
[irreversible commitment (Irrev.)], have been treated for 25 min. with 10% FBS or 10% FBS and 500 pM LIF (+), as indicated, 
before harvesting. Sample numbers correspond to the conditions compared in Tables 1 to 7 (see Additional file 1). C) Quality 
controls of LIF response: Protein RIPA cell extracts from ES cells grown with LIF for 48 h or without LIF for 24 or 48 h and not 
treated (-) or treated for 25 min with FBS or FBS and LIF as in B). Western blot analysis were performed with antibodies 
reacting against all forms of STAT3 (STAT3), the activated STAT3 (P-STAT3 Tyr705) or with OCT4 and ERK2. D) Semi-quan-
titative RT-PCR performed with total RNAs from ES cells grown as indicated in B), have been performed with primers corre-
sponding to the indicated genes.
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pho-ser727 STAT3 protein leading to the formation of
active STAT3-DNA complexes (Figure 1A).
Gene profiling experiments were carried out with mRNA
extracted from the CGR8 mouse ES cell line cultured
under growth conditions as defined in Figure 1B. Cells in
Pluripotent (Pluri), reversible (Rev.) or irreversible
(Irrev.) commitment states were treated with serum or
serum and LIF, 25 min. before harvesting. Protein lysates
were also prepared in parallel with RNA samples. Analysis
of LIF-dependent induction of STAT3, as detected by the
extent of its phosphorylation, confirmed LIF responsive-
ness of pluripotent, reversibly, and irreversibly committed
cells. In addition, we observed a progressive decrease in
the levels of STAT3 protein after 24 h and 48 h of LIF star-
vation, which correlates with the loss of cell pluripotency.
In contrast, no changes in OCT4 protein level was
observed at these early times of cell differentiation. As
expected, the amount of ERK2 proteins was unaltered
under these various conditions and therefore, it was used
as a protein loading control (Figure 1C). The quality of
mRNA hybridized to microarrays was checked by RT-PCR
experiments on a control (Hprt) and known LIF-induced
genes as Socs3, JunB and Fos and the pluripotent Klf4 gene,
[23,48], (Figure 1D).
2) Gene expression profiling in the absence or presence of 
LIF
Five independent total RNA preparations from each con-
dition, (Figure 1B), were processed and hybridized on the
Mouse Genome 430 2.0 Array (Affymetrix) which
includes 45101 probe sets. After RMA normalisation [49]
and outlier removal, pairwise comparisons have been per-
formed using the paired Student t-test (summarized in
Figure 2). This allows the classification of genes into 7
tables (Tables 1 to 7, see Additional file 1). In addition,
multiple testing correction has been performed using the
Benjamini and Hochberg procedure [50,51], as described
in the Methods section.
Tables 1 and 2 show the sets of the LIF-regulated genes
detected in ES cells reversibly and irreversibly committed
to differentiate following acute treatment with LIF. Genes
whose expression was induced by LIF, named hereafter
Lifind genes, belong to various gene families including the
Early growth response genes (Egr1,2), members of Imme-
diate early response (Ier2 and 3), and of Kruppel-related
gene (Klf4 and 5) families, Ras-dex1, Ypel2 and the PI3K
regulator Dapp1. In addition, an EST of unknown func-
tion, 1459961_at, encoded by a gene localized at proxim-
ity of the Stat3 locus (5' to the promoter) has also been
retrieved (named Stat3Loc, see Additional file 2). A sub-
group of genes induced after 24 h of LIF withdrawal was
also induced after a 48 h period of LIF starvation (com-
pare Tables 1 and 2). In addition, few LIF-repressed genes
(Lifrep genes), with the extent of repression less than 2-
fold, were retrieved 24 h after LIF withdrawal (Ddh2,
Mtss1, Chd8 and ESTs), and no repressed genes were iden-
tified after 48 h of LIF starvation. While our stringent cri-
teria of gene selection by the t-test analyses do not lead to
the identification of LIF-modulated genes in pluripotent
cells (+ LIF conditions), we detected a LIF-dependent
increased expression of some genes, including Ypel2,
Plscr1, Dapp1, JunB, Stat3Loc and Klf5, in pluripotent cells,
by semi-quantitative RT-PCR analysis (see below, Figure
4). Altogether, these results showed that the LIF response
was different in pluripotent, reversibly and irreversibly
committed cell populations, suggesting that LIF outcomes
do not rely on the sole activation of STAT3, similarily
induced in these three conditions.
Tables 3 and 4 depict pair-wise comparisons of genes
whose expression was significantly diminished after 24 h
(Table 3) or 48 h of LIF starvation (Table 4) in compari-
son to pluripotent cells (+LIF conditions). In this analysis,
Lifind genes, as defined in Table 1, were also retrieved (as
Socs3, Junb and Klf4) indicating that some cell fate-regu-
lated genes could also be reinducible by LIF, a property
not shared by the majority of genes retrieved in these
Tables. This analysis allowed to identify the core "Pluri"
genes including known pluripotent markers such as Stat3,
Nanog, Klf4, Yes, Zfp42/rex1, Bcl3, Spp1, Cd9, Esrrb, Tbx3,
Tcl1  [25,47] and members of gene families not yet
described to be regulated in the ES cell model. We identi-
fied genes encoding for proteins involved in cell adhesion
(as  Ceacam1  and 2), Wnt (Fzd5, Mitf,  Aes), Ras (Mras,
Ulk1), Notch (Notch4), Interleukin1 (Irak3) and Tgfb
(Bmp4, Inhbb) signalling pathways, in cytoskeleton organ-
ization (Mapt/Tau, Myosin IF, Pdgfa), and in lipid (Abca1,
Cpt1a) and superoxide anion metabolism (Sod2). Many
transcription factors (Tcfcp2like1,  Trps1,  Sox21,  Arid5b,
Nr0b1, Zfp57, Musculin) and chromatin regulators (Myst4)
were also identified.
Tables 5, 6 and 7 gather genes whose expression increases
upon LIF withdrawal. Twenty genes, whose expression
level was up regulated in irreversibly committed cells ver-
sus pluripotent cells, were also expressed in reversibly
committed cells (genes quoted as "YES" in Table 5, like
Lef1, Wt1, Dnmt3a and b, Oct6 and Otx2). This findings
suggest that irreversible commitment maybe linked to the
sustained expression of a set of genes expressed at earlier
time following LIF withdrawal. In table 5, we noted that
the majority of genes (120 out of 140) has a particular
expression profile characterized by low level of expression
in pluripotent cells, high level of expression in reversibly
committed cells and low level of expression again in irre-
versibly committed cells ("low-high-low" profile, quoted
as "NO", in Table 5). These genes, including Bhc80, Bicd1,
Six4, Bmi1, Aire, Jmjd1c, Jmjd2c and Tle4, define a new cat-BMC Genomics 2009, 10:73 http://www.biomedcentral.com/1471-2164/10/73
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egory of genes, whose expression is transiently induced in
reversibly committed cells (see also below, in Figure 3).
Table 7 includes genes induced at 48 h versus 24 h of LIF
starvation. Some of these genes are specific of the irrevers-
ibly committed cells.
3) Gene clustering of all conditions
We performed an ANOVA (F-test) on data obtained under
the different cell growth conditions. The expression pro-
files of highly significant differentially expressed genes
[pvalue < 10-6 with a FDR (False Discovery Rate) of 1.48.
10-4; n = 292] have been categorized using hierarchical
clustering. This allowed to group genes with similar
expression profiles, an indication of potential co-regula-
tion and common functions [52]. Tree view representa-
tion of the clusters led to the identification of eight
independent groups of genes (Figure 3). The upper den-
drogram shows the expected clustering of the different cell
growth conditions with the pluripotent state in one
branch (pluri.), and the reversibly (r. com.) and irreversi-
bly (ir. com.) committed conditions in the other branch.
The complete list of genes of the cluster analysis is availa-
ble (see Additional file 3).
Cluster 1 (similarity score = 0.7547) includes genes whose
expression, induced at 24 h of LIF starvation, is sustained
at 48 h (Foxp1, Enpp3, Otx2, Pak1, Wt1, Gja1, Lef1 and
Fzd7). Cluster 3 (similarity score = 0.8354) defined the
Summary of pair-wise comparisons Figure 2
Summary of pair-wise comparisons. A) LIF-induced (Lifind) or repressed (Lifrep) genes, in pluripotent cells (samples 1 and 
2) or after 24 h (samples 3 and 4) or 48 h (samples 5 and 6) of LIF withdrawal, B) Pluri. genes and C) Markers from reversibly 
and irreversibly committed cells, were retrieved by pair-wise comparisons after a student t-test analysis with the p-value and 
fold change cut off as indicated for each Table, see Additional file 1. Each thick line indicated the condition for which the 
number of genes has been filtered, after t-test analysis, versus the other condition. Pluri: Pluripotent; Rev.com.: Reversible 
commitment; Irrev. com.: Irreversible commitment.
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Identification of eight independent gene clusters Figure 3
Identification of eight independent gene clusters. A) Each probe set is represented by a single row of colored boxes 
and single column represents each microarray. Cells with increasing up regulation colored with yellow of increasing intensity 
and increasing downregulation is colored with blues of increasing intensity. The similarity trees on the top (pluri.: Pluripotent; 
r. com.: reversible commitment; ir. com.: irreversible commitment) and on the left side, represent the similarity matrix of 
probe sets or microarrays. §: Samples treated 25 min. with FBS and LIF. B) Semi-quantitative RT-PCR of a selection of genes 
from clusters 1 to 7. Representative results, from 4 independent experiments, are shown.
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differentiated markers specific of the irreversibly commit-
ted cells, like Car4,  Embigin,  Fgf5,  Ptpn13,  Irx3,  Fgfr11,
Rbp7, some of them corresponding to known cell lineage
markers such as Fgf5.
Clusters 2 (similarity score = 0.7938) and 7 (similarity
score = 0.7109), are the mirror image from each other and
define new atypical gene behaviors. Modulation in the
expression level of these genes was only detected in the
reversibly committed cell population. Indeed, the expres-
sion profile of these genes is: "high-low-high" (Cluster 2)
or "low-high-low" (Cluster 7) in "pluri – r.com – ir.com"
cell growth conditions. Among genes from Cluster 2 we
identified Vimentin, Hspb8 and Jund2. Genes from Cluster
7 include transcription factors like Mlr2, Aire, Tle4 and
chromatin regulators as Bhc80, Smarca2. Genes from these
clusters might be necessary to regulate the transition from
pluripotent to irreversibly committed cells and their iden-
tification would not have been possible without the clus-
tering of all data obtained in our experimental conditions.
Clusters 4 (similarity score = 0.8109), 5 (similarity score =
0.8170) and 6 (similarity score = 0.7163) define genes
highly expressed in pluripotent cells and whose expres-
sion level, was i) abruptly decreased 24 h following LIF
starvation (in Cluster 5: Pim3, Fzd5, Sod2, Esrrb, Tcfcp2l1,
Mras, Gjb3 and 5, Bcl3, Stat3, Smarcd3, Yes and Cd9), ii)
progressively decreased, (in Cluster 4: Stmn1  and  2,
Scarb2, Timp1, Pcolce, Tcl1 and Trps1) or iii) decreased only
48 h after LIF starvation (in Cluster 6: Lgals3, Cordon bleu,
Vegfc, Zfp74, Hist1h1c). Genes from cluster 5 are named
"Pluri" genes thereafter.
Cluster 8 (similarity score = 0.7488) includes genes whose
expression was induced by LIF in both reversibly or irre-
versibly committed cells. Only one gene (probe set
1446583_at) was found repressed by LIF in this analysis.
The regulated expression of a selection of genes from each
cluster and Tables 1 and 2 (see Additional file 1) was val-
idated by semi-quantitative RT-PCR (Figures 3B, 4A and
4B).
4) Cell fate-independent and cell-specific Lifind genes
To determine whether the Lifind genes from Table 1 (see
Additional file 1) are modulated by LIF in other cellular
context, we analysed their expression profile with the
heatmapper tool, under our set of conditions (Figure 5A),
and in an embryoid body (EB) kinetic analysis following
LIF withdrawal, from day 1 to day 10 (Figure 5B). Indeed,
we had previously shown that some LIF targets (like Socs3,
Fos and JunB) are expressed, several days after LIF with-
drawal, in differentiated cells [46]. In this study, we
extended this analysis and showed that almost all the
genes induced by LIF in reversibly and irreversibly com-
mitted cells, are re-expressed, concomitantly with the re-
expression of LIF and of its receptors (gp130 and gp190)
at day 10 of EB differentiation (Figures 5B and 5C). In
contrast, genes marked with an asterisk in Figure 5A are
not re-expressed (see Figure 5B). Therefore, we have char-
acterized two types of Lifind genes: those induced by LIF at
24, 48 h and 10 days after LIF withdrawal and which cor-
respond to cell fate-independant LIF targets [named here-
after "Pleio-Lifind"  genes and including Socs3, Fos and
JunB] and genes whose induction by LIF is cell-restricted
[named hereafter "Spe-Lifind"genes] and which were not
known, so far, as LIF targets.
5) Regulation of "Pluri" genes in embryoid bodies kinetic 
following LIF withdrawal
Genes from Cluster 5 (represented in Figure 6A), were also
analysed with the heatmapper tool in the time course of
EB differentiation (Figure 6B). Master genes, Oct4, Sox2
and Nanog, whose expression is stable up to day 2 (Sox2)
or day 3 (Oct4 and Nanog) and which are therefore not
present in cluster 5, were manually added for this analysis.
Three groups of genes were identified: i) those strictly
expressed in pluripotent cells (red line, Cluster a), includ-
ing pluripotent cell marker like Esrrb; ii) those re-
expressed at day 10 of the EB diffentiation kinetic (blue
line, Cluster b), including the LIF-dependent Cd9 gene
[39], and iii) genes whose expression was higher in differ-
entiated than in pluripotent cells (blue line, Cluster c),
including Stat3. This analysis helps to identify relevant
new genes potentially involved in the maintenance of ES
cell pluripotency, since known pluripotent markers are
present in each of these clusters.
6) Analyses of Lifind and Pluri gene expression in Oct4 
and Nanog knock-down experiments
The overall expression level of Oct4 and Nanog was unal-
tered up to three days upon LIF withdrawal in the kinetic
of embryoid bodies (Figure 6B). However, the recent find-
ing that ES cells are heterogeneous for the expression of
many markers, like NANOG but no OCT4, prompted us
to determine whether the expression level of genes identi-
fied in this study could be directly modulated by these
master genes. This should help to find a specificity of
these core "pluripotent master genes" [53,54]. We have
analysed expression profiles of Lifind and Pluri genes after
knock-down of Nanog and Oct4 by RNAi. Availability of
Affymetrix data, from Loh et al, [19], performed with
mouse ES cells infected with lentivirus expressing shNanog
or shOct4 silencing RNAs, allowed such an analysis. Heat-
mapper analyses were performed with Lifind (Figure 7A)
or Pluri genes (Figure 7B). The expression of Lifind genes
are either repressed like Ier2, Socs3, klf5 or Egr1 (Figure 7A,
Cluster 1) or induced like Zfp36, Fos and Rasd1 (Figure 7A,
Cluster 2) by Oct4 knock down. Remarkably, Ier3 is the
only Lifind gene whose expression is repressed by NanogBMC Genomics 2009, 10:73 http://www.biomedcentral.com/1471-2164/10/73
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silencing. In addition, this analysis emphasizes the partic-
ularity of some Spe-Lifind genes (like Pabpc1, Plscr1, Dapp1
and Dyst) and of JunB, Sbno2 and Egr2 whose expression
is altered neither by Oct4 nor by Nanog silencing.
A similar analysis has also been conducted with the Pluri
genes (Figure 7B), highlighting their differential regula-
tion by Oct4 or Nanog. Indeed, we identified 5 groups of
genes whose expression is down (like Sox2,  Irak3  and
Susd2 in Figure 7B, Cluster 1) or up (like Cd9, Gjb3 and
Gjb5 in Figure 7B, Cluster 5) regulated following Oct4 but
not Nanog silencing or down regulated by independent
silencing of both genes (like Esrrb, Ly6 and Sod2 in Figure
7B, Cluster 2 and part of Cluster 4 including Slc11a1,
Nanog  and  Fblim1). The expression of only one gene
(Ceacam1) was increased by Nanog silencing (Figure 7B,
Highlights on Cluster 8 Figure 4
Highlights on Cluster 8. A) Tree view representation of Lifind genes, regulated similarly by LIF in r. com. (reversible com-
mitment) and ir. com. (irreversible commitment) conditions and validation of a selection of genes by semi-quantitative RT-PCR, 
B) Validation of a selection of Lifind genes retrieved by the t-test analysis. §: Samples treated 25 min. with FBS and LIF. Repre-
sentative results, from 4 independent experiments, are shown.
+ + + 25’ FBS -- -
A
Dapp1   
1458308_at
Ypel2
1457824_at
Rd 1
+
+
+
++
+ 25  FBS
25’ FBS and LIF ---
pluri.       r. com.    ir. com.
Stat3-Loc
Socs3
Zfp36
Rasd1
JunB
Fos Cluster 8
§§§§§ §§§§§ § § § §§
Pim 3
Egr1
Klf5
Nfkbiz
Klf4
T-test Analysis 
(Tables 1 and 2)
B
Egr2
Ier3
Ier2
(Tables 1 and 2)
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Cluster 3). These analyses define novel gene categories,
not similarly regulated by master genes, which might be
part of novel sub-networks involved in the regulation of
ES cell pluripotency.
7) Effects of knock-down of a selection of Lifind and Pluri 
genes in pluripotent cells
In silico analyses allowed us to select genes among the
Lifind and Pluri genes for further functional studies. We
focused our efforts on a selection of Spe-Lifind  genes
(Dapp1, Plscr1, Dyst, Pabpc1) and also included Ier3 owing
to its particular expression profile in Oct4  and  Nanog
silencing experiments. Concerning the Pluri genes, we per-
formed the experiments with genes specifically expressed
in pluripotent cells such as Irak3, Susd2 and  Ly6  and
whose expression was affected by only one master gene
(Oct4), except Ly6, which behaves as Esrrb, a recently iden-
tified pluripotent marker [25,55,56]. We have also
included Tcfcp2l1, a transcription factor strictly expressed
in pluripotent cells (Figure 6B, Cluster a).
We have tested the function of these genes using an RNA
interference strategy. Endoribonuclease prepared (e) siR-
NAs [57] were generated, targeting the different genes. ES
cells were transfected twice with each esiRNA and stained
with Alkaline phosphatase (ALP) five days after the first
transfection (see Additional file 4). Knock-down of Stat3
and Oct4 led to morphological cell differentiation (with
loss of ALP staining), and proliferative defects similar to
that observed when LIF was withdrawn for 4 to 5 days,
consistent with their known function in maintaining
pluripotency (positive controls). Knock-down of the vari-
ous genes tested did not induce significant morphological
changes, as shown for Ier3 as well as for the other genes
tested (see Additional file 4 and results not shown). How-
ever, alteration in gene expression level (as shown in Fig-
In silico analyses of Lifind genes in various microarray experiments Figure 5
In silico analyses of Lifind genes in various microarray experiments. Tree view representation of Heatmapper analyses 
of Lifind genes retrieved from Table 1 and analysed with Affymetrix data from reversibly (rev.) and irreversibly (irrev.) commit-
ted cell populations A), and in a kinetic of LIF withdrawal [day 1 (d1) to day 10 (d10) in EBs], B). The validation of the expres-
sion of LIF cytokine and of its composite receptor (gp130 and gp190), performed by RT-qPCR on three independent 
experiments, is shown as histograms with standard deviations in C). The asterisks point to genes not reinduced by LIF in differ-
entiated cells (d10 EBs).BMC Genomics 2009, 10:73 http://www.biomedcentral.com/1471-2164/10/73
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ure 3) occurred much earlier than morphological changes,
which are observed at three days upon LIF withdrawal (see
Additional file 4A) and as morphological changes, which
are observed at three days upon LIF withdrawal, as shown
in Figure 3A and as reported in other ES cell lines, [47,58].
This prompted us to analyse the effects of gene silencing
on the expression of early differentiation markers. Expres-
sion level of Lef1, Pak1, Car4 and Dnmt3a, all induced at
24 or 48 h of LIF withdrawal (see Figure 3), was analysed
after 5 days of transfection in ES cells grown with LIF. The
expression of Nestin, Gata4, Gata6 and Sox17, induced at
later times of LIF withdrawal, was also studied. The effi-
ciency of the silencing of each esiRNA was determined by
RT-qPCR and shown to be in the range of 50 to 80% (see
Additional file 5 and not shown). The expression of
almost all the differentiation markers tested was modu-
lated by the silencing of Stat3 or Oct4. However, individ-
ual silencing of the selection of Lifind or Pluri genes led to
no effects or modest up regulation of some of the tested
differentiation markers (see Additional file 5).
Discussion
From pluripotent to irreversibly committed cells: The LIF 
impact
By gene profiling studies performed with pluripotent
murine ES cells and with reversibly or irreversibly ES-
derived committed cells, treated or not with LIF, we end
up with a new global view of the genetic program leading
from pluripotent to differentiated cells, as summarized in
Figure 8: When LIF is withdrawn for 24 h, cells enter the
commitment phase and the expression of 59 genes
declines (like Bcl3, Klf4, Stat3, Yes, Esrrb, Nanog, M-ras,
In silico analysis of Pluri genes Figure 6
In silico analysis of Pluri genes. Heatmapper analysis of genes from Cluster 5 (as defined in Figure 3 and represented here in 
panel A) has been performed with Affymetrix data taken from the kinetic of LIF withdrawal (d1 to d10 of EBs differentiation), 
B). Relevant clusters are highlighted by red (a) or blue lines (b and c). The asterisks point to three master genes, sox2, oct4 and 
nanog manually included in this analysis.BMC Genomics 2009, 10:73 http://www.biomedcentral.com/1471-2164/10/73
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Fzd5), while the expression of 140 genes increases (like
Lef1, Otx2, Wt1, Dnmt3a, b and Fzd7). When LIF is added
back at this stage, twenty genes are induced (like Socs3,
Klf4 and 5, JunB, Egr1, 2, 3, Ier 1, 2, 3; Zfp36) and twelve
are repressed. This type of treatment allows cells to main-
tain their pluripotent state, as illustrated by their ability to
colonize blastocysts and produce chimera almost as effi-
ciently as cells kept under the continuous presence of LIF
[24,38,45,47,59]. When LIF is withdrawn for 48 h, the set
of genes repressed, in comparison with the pluripotent
cells, is larger than at 24 h of LIF starvation. Some of these
genes (16 genes, like Oct6, Lef1, Otx2, Wt1, Dnmt3a) are
already expressed by reversibly committed cells suggesting
that their sustained expression might be critical for the
establishment of the differentiated state. Among them,
Otx2 was recently shown to be a critical regulator of early
cell differentiation [25]. LIF treatment of cells starved of
LIF for 48 h does not reset the stemness program as shown
by their inefficiency to form teratomas or colonize blasto-
cysts [45,59]. Our statistical study reveals differences in
the set of LIF targets induced after a 24 h or a 48 h period
of LIF starvation. Indeed, only a portion of the genes iden-
tified in reversibly committed cells was induced by LIF in
irreversibly committed cell population. In addition, the
extent of LIF induction was less than half that observed in
reversibly committed cells, despite the fact that STAT3
phosphorylation and activity remained very high in both
situations. This suggests that activated STAT3 could regu-
late a cell-state-dependent pathway which locks cells in a
differentiated state.
In silico analysis of Lifind and Pluri genes: Regulation by OCT4 or NANOG Figure 7
In silico analysis of Lifind and Pluri genes: Regulation by OCT4 or NANOG. Heatmapper analyses performed respec-
tively with LifindA) and PluriB) genes whose level of expression was analysed in microarray experiments taken from Loh et al, 
[19]. Relevant clusters are marked with black lines and numbered. Color code is like in Figure 3. yellow: expression above the 
median; black: median expression; blue: expression below the median.BMC Genomics 2009, 10:73 http://www.biomedcentral.com/1471-2164/10/73
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Three LIF-dependent signatures
Our analysis has allowed also to distinguish between Spe-
Lifind (genes induced by LIF in a restricted cellular con-
text), Pleio-Lifind (genes induced by LIF in various cellular
context and potentially involved in pleiotropic effects of
LIF) and Pluri genes. This last category corresponds to LIF-
dependent genes, not reinducible by LIF in the first 48 h
of differentiation (summary in Figure 8). Some of the
Pleio-Lifind genes are known for their impact on stemness,
[like Klf4 or Socs3 [23,41,48]], in trophoblast differentia-
tion (like Socs3, [60]) and for their activation in the M1
myeloid cell line, in which LIF is pro-differentiative (like
JunB and Egr1 [61-63]). However, none of the Spe-Lifind
genes have previously been identified as LIF targets. Many
of these genes are not well characterized, and their poten-
tial responsiveness to LIF could help unravelling their
function. In addition, the comparison of LIF regulated
genes identified in our study with those reported in micro-
array analyses, performed on other cell types or tissue [car-
diomyocytes [64], neurons [65] and uterus [66]], shows
no overlap except stat3 (summary in Figure 9). However,
both the different timing of LIF induction (25 min. in our
study versus several hours in these other studies) and cell
context, [48,67,68], might account for this absence of
overlap. Our screen reveals also a partial overlap between
LIF targets identified in this study, and STAT3 targets, pre-
viously reported [47,69] suggesting that LIF and STAT3
pathways might have various outcomes which are not yet
fully identified, and that LIF-dependent response might
not be under the sole control of STAT3.
Our screen revealed that there are few LIF-repressed genes.
This emphasizes the point that LIF effects are regulated
through the synthesis of repressors (e.g., Socs3). Mereover,
new LIF-induced negative regulators might be critical for
maintenance of cell pluripotency. Such a candidate could
Highlights of microarray analyses performed in pluripotent, reversibly and irreversibly ES-derived committed cells, treated or  not with LIF Figure 8
Highlights of microarray analyses performed in pluripotent, reversibly and irreversibly ES-derived committed 
cells, treated or not with LIF. A selection of genes regulated in each cell state is presented. Bolded genes are the pleio-Lifind 
genes, identified in the ES cell system or in other LIF sensitive cell types.
Transient modulation of 
gene expression:
Up-regulated: Smarca2, Tle4, 
Aire, 1443167_at….
Down-regulated: Mapk13, 
D8ertd82e, Hspb8….
Pluri. Rev. com. Irrev. com
Pluripotency genes:
Stat3, Rex1, Zfp57, Nanog, Tbx3, Cd9, 
Commitment genes:
Pak1, Lef1, Fzd7, Dnmt3a, Wt1, 
Differentiation genes:
Pak1, Lef1, Fzd7, Dnmt3a, Wt1,
+LIF -LIF24H -LIF48H
Cd81, Ceacam 1 and 2, 
Gjb3 and 5, Inhbb, 
Mras, Irak3, Sod2, Bcl3, Yes, Bmp4, 
Esrrb, Tcl1, 
L 6 6 T f 2 T f 2L1
Irp2, Otx2, Kif21a, Atbf11, Dll1…. lrp2,O t x2, Kif21a, Atbf11, Dll1….
Car4, Ptnp13, Irx3, Fgf5, Nestin, 
Oct6, Pim2, Dnmt3b, Fzd2, 
Prominin1, Embigin, Cd24a….
Ly6g6e, Tcfap2c, Tcfcp2L1,
Susd2, Smarcd3, Esgp, Emp1 … Lifind genes :
Socs3, JunB, Fos, Egr1, Zfp36,
Ier2, Ier3, Egr2, Klf4, Klf5, 
Rasd1 Nfkbiz Dapp1 Ypel2
Lifind genes:
Socs3 JunB Fos Egr1 Egr2 Rasd1, Nfkbiz, Dapp1, Ypel2, 
Dystonin, Pabpc1, Etv6 ….
Lifrep genes:
Ddh2, Mtss1, Chd8….
Lifind genes:
Ypel2 , Dapp1, junB, klf5
Socs3, JunB, Fos, Egr1, Egr2 
Zfp36, Ier3, Rasd1….
No LIF-repressed genes.BMC Genomics 2009, 10:73 http://www.biomedcentral.com/1471-2164/10/73
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be Zfp36, which encodes for a protein involved in mRNA
stabilization through the ARE (Au Rich Element)
sequence [70,71]. We found that a proper level of this pro-
tein was necessary to ensure survival of pluripotent cells
since its overexpression led to cell death (our unpublished
results). Along with the recent finding that ZFP36 regu-
lates directly the stability of Ier3 mRNA [72], a new Lifind
gene identified in that study, it is tempting to propose that
differential stabilisation of mRNAs could have an impact
on the survival of pluripotent ES cells.
Lifind genes regulation by OCT4 or NANOG
We have classified Lifind genes into different sub-groups
depending on their differential regulation by Oct4  or
Nanog  (summary in Figure 10). Expression of almost
none of the Spe-Lifind genes is modulated by the silencing
of these two master genes, emphasizing their belonging to
a LIF specific pathway [18,20,73]. However, the individ-
ual knock-down of four of these genes (Dapp1, Plscr1, Dst
and Pabpc1) does not lead to morphological changes nor
to a significant alteration in the expression of a selection
of early differentiation markers. Disruption of all four
genes together might be required before any effect
becomes apparent. Alternatively, these genes could be
involved in the reversibility of committed cells grown
without LIF for 24 h, [38,74], a potentiality not tested in
the present study.
Novel characteristics of Pluri genes and differential 
regulation by OCT4 or NANOG
The Pluri genes retrieved in this analysis include genes pre-
viously shown to maintain cell pluripotency like Yes, Cd9,
Esrrb, Tcl1 and Tbx3 [21,25,33,39]) and many novel genes
(summary in Figure 8). We show that Pluri genes could be
endowed with new features, which might be relevant to
explain cell fates. Indeed, while expression of known mas-
ter genes (Oct4, Sox2 and Nanog) is maintained for 2 or 3
days following LIF withdrawal, expression of almost all
the genes identified in our analysis (Figure 3A, Cluster 5)
is decreased on the first day of LIF withdrawal like Esrrb or
Pim3, recently identified as new pluripotent genes
[25,75]. The direct targets of Esrrb and Tcfcp2l1 (both in
Cluster 5) was recently characterized, allowing the identi-
fication of novel regulatory complexes and stressing the
potential importance of sub-networks to regulate cell
pluripotency [55]. Also, some of these genes are re-
expressed 10 days after LIF withdrawal, therefore becom-
ing LIF responsive in these differentiated cells. In addi-
tion, the silencing of Oct4  or  Nanog  decreases the
expression of many of these genes together, potentially
A) Compilation of a selection of microarray data and comparison with our results Figure 9
A) Compilation of a selection of microarray data and comparison with our results. Microarray experiments have 
been compared with our analysis. Genes in common with those identified in our analysis are bolded. B) Comparison of 
Lifind genes in ES cells and other cell types and organ. This table is a compilation of results obtained in various LIF-
responsive cell types (cardiomyocytes and neurons) and organ (uterus).
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explaining why the individual knock-down of some of
these Pluri genes does not affect cell pluripotency.
We have identified genes whose expression depends of
Oct4 only (like Irak3, Susd2) or of both Oct4 and Nanog
(like Esrrb, Fzd5, Ly6 or Sod2) or of none of them. Genes
whose expression is induced by Oct4  (including  Gjb3,
Gjb5 and Cd9) or Nanog silencing (Ceacam1), have also
been identified (data sumarized in Figure 10). However,
for unknown reasons, these genes were almost not
expressed in pluripotent cells used in the study of Loh et
al., [19] while highly expressed in the CGR8 cells used in
our study and could be among genes whose expression
fluctuates between various types of ES cells, as already
described [76].
24 h without LIF: a critical window for cell fate choices
In this study, we also demonstrated that upon LIF with-
drawal, cells go through a transition phase in which the
expression of a new set of genes is modulated. Hierarchi-
cal clustering analysis was of fundamental importance for
the characterization of two types of gene clusters, which
displayed "high-low-high" (Figure 3A, cluster 2) or "low-
high-low" (Figure 3A, cluster 7) expression levels in the
three cell fates analysed "pluripotent, reversibly and irre-
versibly committed". Some of these genes, (Table 5, see
additional file 1), from the Jumonji family, encoding for
specific Histone demethylase, have recently been reported
as being essential for the maintenance of ES cell pluripo-
tency [77]. In addition, among genes from cluster 7, tran-
scription factors (Tcfec, Zfp532) and chromatin regulators
(Bhc80, Smarca2 and Tle4) might be critical for the regula-
tion of the expression of genes of cluster 2 (Mapk13,
Lifind and Pluri gene expression in ES cells in which the expression of Oct4 or Nanog has been knocked-down Figure 10
Lifind and Pluri gene expression in ES cells in which the expression of Oct4 or Nanog has been knocked-down. 
Summary of Pleio- and Spe-Lifind gene regulation A), and of Pluri gene regulation B), by Oct4 and/or Nanog, based on the heat-
mapper analysis.BMC Genomics 2009, 10:73 http://www.biomedcentral.com/1471-2164/10/73
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Hspb8, Vim and Jundm2) [78]. The functional role of these
new gene clusters, to drive the transition from pluripotent
to irreversible differentiation, will be a future goal.
Conclusion
Our work has provided a novel global view of LIF
reponses in mES cells and in their early-derived deriva-
tives and allowed the identification of various sets of LIF-
induced (Lifind) and Pluripotency (Pluri) genes. We have
also characterized sub-networks of genes whose expres-
sion is modulated while the master knot (composed of
OCT4, SOX2 and NANOG) is still expressed, and which
are partly under Oct4 and/or Nanog control. Furthermore,
our study has led to the identification of gene clusters with
atypical expression profiles, which desserve to be studied
in details for their potential function in ES cell physiology.
The recent demonstration that mouse ES cells are hetero-
geneous for the expression of different genes, like Rex1
[79], Nanog [53] and many others characterized by in situ
hybridization [54], along with the identification of new
genes from this study, open new roads for understanding
and controlling ES cell plasticity.
Methods
Cell culture, treatments for microarrays and reagents
The CGR8 (feeder free) ES cell line (from 129SV mouse)
was grown in DMEM, high glucose (Gibco), supple-
mented with 0.1 mM β2Mercaptoethanol, 10% Foetal
Bovine Serum (FBS), 400 μg/ml gentamycin and human
LIF (500 pM). Cell medium was changed every other days.
For microarray experiments, plated ES cells were diluted at
105 cell/ml in ES cell medium with or without LIF. The
plating efficiency was similar in the presence and absence
of LIF and cells have not been diluted during the 48 h of
the experiment. At 24 or 48 h upon LIF withdrawal, cells
were treated for 25 min., with medium containing FBS or
FBS and LIF, before harvesting. Cells grown in the com-
plete medium with LIF were treated similarly after 48 h of
cell growth.
The anti P-STAT3 Tyr705 (Cell signalling), P-STAT3 Ser
727 (gift from Dr. Frank, [80], anti-STAT3 (F-2, Santa
Cruz), anti-OCT4 (Abcam) and anti-ERK2 (Santa Cruz)
antibodies were used as recommended by the manufac-
turer.
For the differentiation of CGR8 ES cells by LIF withdrawal
(embryoid body formation), hanging drop protocol was
executed as described previously [81]. Briefly, an ES cell
suspension of 2.5 × 104 cells/ml was prepared in Iscove's
modified Dulbecco's Medium (IMDM) supplemented
with 20% FBS, 1% non-essential amino acids (vol/vol), 2
mM L-glutamine, and 100 μM β-ME. Of this ES cell sus-
pension, 20 μl was spotted on the inside of the upper lid
of a 10 cm bacteriologic dish and then covered over its
bottom dish containing 5 ml phosphate-buffered saline.
On day 2, the formed multicellular Embryoid Bodies
(EBs) were transferred into suspension in a new dish with
IMDM supplemented with 20% FBS, 1% non-essential
amino acids (vol/vol), 2 mM L-glutamine, and 100 μM β-
ME. On day 7, the EBs were plated on gelatin coated tissue
culture dishes. RNA was isolated from ES cells (main-
tained with LIF, d0) and from differentiating EBs [cul-
tured in the absence of LIF for one day (d1) to day 10
(d10)] on an exact regular interval of 24 hours.
Microarray experiments: Hybridization and data analysis
Total RNAs were prepared with the Qiagen column kit
(Qiagen) and treated with DNAse (5 U/100 μg RNA,
Sigma). Biotinylated cRNA was prepared according to the
standard Affymetrix protocol (Expression Analysis Tech-
nical Manual, 1999; Affymetrix). In brief, double-
stranded cDNA was synthesized from 10 μg total RNA
using the SuperScript Choice System from InVitrogen and
the Affymetrix T7-(dT)24 primer which contains a T7 RNA
polymerase promoter attached to a poly-dT sequence. Fol-
lowing phenol/chloroform extraction and ethanol precip-
itation, the cDNA was transcribed into biotin-labeled
cRNA using the Retic Lysate IVT™ kit (Ambion Inc., Wood-
ward Austin, TX, USA). The cRNAs produced were purified
using RNeasy kit (Qiagen) and fragmented to an average
size of 30–50 bases according to Affymetrix recommenda-
tions. 15 μg of fragmented cRNAs were hybridized for 16
hr at 45°C on the Mouse Genome 430 2.0 Array. This
array integrates 45101 probe sets, including 26275
sequences characterised in Entrez databases and 5069
anonymous ESTs. Arrays have been washed and stained in
the Affymetrix Fluidics Station 450 and further scanned
using the Affymetrix Gene-Chip scanner 30007 G. The
image data were analyzed with the GeneChip® Operating
Software (GCOS) using Affymetrix default analysis set-
tings. Arrays – after passing the quality control – have
been commonly normalized by the log scale robust multi-
array analysis (RMA, [49]). After outlier removal using the
Nalimov test at p < 0.001, a parametric ANOVA (F-test)
has been applied to get global expression differences
between the six different conditions. Multiple testing cor-
rection has been performed using the Benjamini-Hoch-
berg procedure [50]. Hierarchical clustering of expression
values of probe sets highly significant, differentially
expressed in the ANOVA (n = 292; pvalue < 10-6 and FDR
< 1,48. 10-4) was performed by using Cluster version 2.11
[52] applying mean-centering and normalization of genes
and arrays before average linkage clustering with uncen-
tered correlation. To detect distinct expression differences
between the growth conditions, paired Student t-tests of
transcripts differentially expressed in ANOVA (FDR <
0,05) have been applied. Student t-test p-values and foldBMC Genomics 2009, 10:73 http://www.biomedcentral.com/1471-2164/10/73
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changes between the conditions, averages and standard
deviations for each condition have been documented.
Heatmapper analysis
Heatmapper tool allows a graphical representation of the
level of expression of many selected genes across a
number of samples from various experimental condi-
tions, as they have been obtained with similar DNA
microarrays (eg: A430 2.0) [82]. The mean "signal" value
from 3 independent experiments obtained from Affyme-
trix DNA analysis [(arrays A430 2.0: d0 to d10 of LIF with-
drawal kinetic on embryoid bodies, (Sachinidis, A. et al,
unpublished results)] have been compared with our cur-
rent data analysis results. A Web-based tool that allows i)
quick browsing of user-provided gene sets, ii) standard
hierarchical clustering [52] and iii) heatmap-visualisation
across multiple data sets, has been created and used for
performing this study. This data analysis environment is
currently being developped further into a systematic
mouse stem cell data analysis atlas (R. Kolde and J. Vilo,
unpublished results). Similarly, samples from Affymetrix
data of Loh et al, [19], available at GEO data base under
the access number: GSE4189, have been added in the
interface created, as a way to perform analyses as shown in
figures 7.
Cell lysates, Western blots and Band Shift experiments
Plated cells were rinced twice with room temperature PBS
and lysed directly in mild RIPA buffer (PBS, 1% triton, 1%
NP40, 0.05% SDS, 1 μg/ml protease inhibitor cocktail, 1
mM Pefabloc, 20 mM NaF, 1 mM Na vanadate) and cen-
trifuged 10 min at 10000 rpm. Cell lysates were resolved
by SDS-PAGE and electro-transferred onto nitrocellulose
membranes. Proteins were reacted with the different anti-
bodies, as recommended by the manufacturers. Band shift
experiments have been performed with nuclear cell lysates
as described [38], with the SIE DNA probe, a high affinity
DNA binding site for STAT3. Band shifs were performed
in the presence of a 100× molar excess of unlabelled wild
type (wt) or mutated (m) competitor oligonucleotides
encompassing the SIE sequence.
Semi-quantitative RT-PCR and RT-qPCR
Total RNAs from adherent ES cells were prepared with the
Qiagen column kit (Qiagen) and treated with DNAse (5
U/100 μg RNA, Sigma). Total RNAs (5 μg) were reverse-
transcribed (RT) with random hexameric primers and the
MLV Reverse Transcriptase (Sigma). The RT reaction prod-
ucts were used for PCR with specific primer sets as
described [48]. Sequences of primers used for all the genes
tested in semi-quantitative RT-PCR (shown in Figure 3)
are in Additional file 6.
Quantification, of the extend of Knock-down and of the
expression of differentiation markers (see Additional file
5), was performed by RT-qPCR with the MX4000 system
(Stratagene) as previously described [83]. The relative
expression of the genes of interest was deduced of the Ct
using the ΔΔCt method with Hprt house-keeping gene as
the reference. Sequences of primers used in RTq-PCR are
in Additional file 7.
The validation of the expression of LIF cytokine and of its
receptors by RT-qPCR analysis (shown in Figure 5C) was
performed with the ABI Prism 7500 Fast System (Applied
Biosystems, Foster City, CA). 1 μg total mRNAs of ES cells
and of EBs, obtained from 3 independent experiments
(biological triplicates), were reverse transcribed with Ther-
moScript™ Reverse Transcriptase (Invitrogen, Karlsruhe,
Germany). Then real-time PCR was performed with tech-
nical triplicates for every sample using TaqMan Gene
Expression Assays (Applied Biosystems, Foster City, CA).
The Gene Expression Assays used were Lif
(Mm00434761_m1),  Lif receptor (gp190)
(Mm00442940_m1),  Interleukin 6 signal transducer
(gp130)  (Mm00439668_m1) and Gapdh
(Mm99999915_g1). Ct values of each qPCR reaction from
the target gene were normalized with the respective Ct val-
ues of the housekeeping gene, Gapdh, that ran in the same
reaction plate to obtain the Δ Ct value. The fold change
was calculated as follows: fold change = 2-(ΔCt gene1 - ΔCt
gene2). The ΔCt of the gene in the sample with the lowest
expression is used as ΔCt gene2 to calculate the fold
change using the above formula. The resulting fold
change is expressed as mean ± SD.
RNAi experiments
Endoribonuclease-prepared short interfering RNA
(esiRNA) was synthesized according to the protocol
described in [57]. Briefly, selected transcripts were ana-
lysed with the software program Deqor [84] to identify
the best region for esiRNA synthesis. Primers with
appending T7-RNA polymerase-tags were designed and
used to amplify gene specific PCR products of about 500
bp in length. These fragments were used to generate
dsRNA that was subsequently digested to esiRNAs with E.
coli RNaseIII. The esiRNA was purified and used to trans-
fect ES cells using Lipofectamine 2000. ES cells were
plated in complete medium without antibiotics, on gelat-
inized 24-wells dishes at day 0, to achieve 60–70% con-
fluency on the day of transfection (day 1). 150 ng of
esiRNA (diluted in qsp 50 μl of serum-free DMEM), was
mixed with 1 μl of Lipofectamine 2000 (diluted in qsp 50
μl of serum-free DMEM). The mixtures were incublated at
room temperature for 20 min. and then added to freshly
trypsinised ES cell culture, in suspension in 400 μl of com-
plete medium (with serum and LIF) without antibiotics.
Medium was changed on day 2 and cells were re-trans-
fected on day 3. Cells were harvested for RNA preparation
or fixed on day 5, 10 min. at 4°C in 2% formaldehyde/BMC Genomics 2009, 10:73 http://www.biomedcentral.com/1471-2164/10/73
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0.2% glutaraldehyde in PBS and stained with the Alkaline
Phosphatase kit (Sigma-Aldrich, 86R-1KT) according to
the manufacturer.
Primer sequences used for esiRNA synthesis are available
on request.
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